Aquestive Therapeutics Inc (AQST) — Cash Flow Reinvestment Rate
Aquestive Therapeutics Inc (AQST) has a Cash Flow Reinvestment Rate of 0.00x as of March 2023, reinvesting $4.00K (capex $2.00K plus investments $-2.00K) from operating cash flow of $8.82 Million. Check Aquestive Therapeutics Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Aquestive Therapeutics Inc Cash Flow Reinvestment Rate (2017–2017)
Historical reinvestment intensity for Aquestive Therapeutics Inc across 1 annual periods. Explore Aquestive Therapeutics Inc (AQST) investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Aquestive Therapeutics Inc (2017–2017)
Year-by-year capital reinvestment analysis for Aquestive Therapeutics Inc. For live market cap and broader valuation context, see AQST market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2017 | 0.71x | $4.14 Million | $5.82 Million | $2.07 Million | — |